BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33428603)

  • 1. The landscape of alternative splicing reveals novel events associated with tumorigenesis and the immune microenvironment in gastric cancer.
    Lou S; Zhang J; Zhai Z; Yin X; Wang Y; Fang T; Xue Y
    Aging (Albany NY); 2021 Jan; 13(3):4317-4334. PubMed ID: 33428603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
    Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
    Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
    Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
    Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer.
    Zhao J; Chang L; Gu X; Liu J; Sun B; Wei X
    Cancer Sci; 2020 Aug; 111(8):3020-3031. PubMed ID: 32530556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Analyses of the Differentially Expressed Alternative Splicing Events in Gastric Cancer and Its Clinical Significance.
    Lin C; Yu B; Zhang M; Chen Y; Li L; Zhao D
    Front Genet; 2020; 11():522831. PubMed ID: 33281863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data.
    Xiong Y; Deng Y; Wang K; Zhou H; Zheng X; Si L; Fu Z
    EBioMedicine; 2018 Oct; 36():183-195. PubMed ID: 30243491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pattern of alternative splicing in lung adenocarcinoma shows novel events correlated with tumorigenesis and immune microenvironment.
    Wang G; Qi W; Shen L; Wang S; Xiao R; Li W; Zhang Y; Bian X; Sun L; Qiu W
    BMC Pulm Med; 2021 Dec; 21(1):400. PubMed ID: 34872548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of alternative splicing events in the diagnosis and prognosis of Gastric Cancer.
    Wei C; Xie W; Huang X; Mo X; Liu Z; Wu G; Meng Y; Jeen F; Ge L; Zhang L; Liao L; Liu J; Tang W
    J Cancer; 2021; 12(10):2982-2992. PubMed ID: 33854599
    [No Abstract]   [Full Text] [Related]  

  • 9. Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.
    Yu S; Hu C; Liu L; Cai L; Du X; Yu Q; Lin F; Zhao J; Zhao Y; Zhang C; Liu X; Li W
    J Transl Med; 2020 Jul; 18(1):286. PubMed ID: 32723333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic profiling of alternative splicing in
    Liu C; Hu C; Li Z; Feng J; Huang J; Yang B; Wen T
    Cancer Cell Int; 2020; 20():279. PubMed ID: 32617077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiles of alternative splicing landscape in breast cancer and their clinical significance: an integrative analysis based on large-sequencing data.
    Du JX; Liu YL; Zhu GQ; Luo YH; Chen C; Cai CZ; Zhang SJ; Wang B; Cai JL; Zhou J; Fan J; Dai Z; Zhu W
    Ann Transl Med; 2021 Jan; 9(1):58. PubMed ID: 33553351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.
    Lai J; Yang H; Xu T
    BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic Analysis of Alternative Splicing Landscape in Pancreatic Adenocarcinoma Reveals Regulatory Network Associated with Tumorigenesis and Immune Response.
    Lu J; Wei S; Lou J; Yin S; Zhou L; Zhang W; Zheng S
    Med Sci Monit; 2020 Jul; 26():e925733. PubMed ID: 32706768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic values of GPNMB identified by mining TCGA database and STAD microenvironment.
    Yao K; Wei L; Zhang J; Wang C; Wang C; Qin C; Li S
    Aging (Albany NY); 2020 Aug; 12(16):16238-16254. PubMed ID: 32833670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiles of prognostic alternative splicing signature in hepatocellular carcinoma.
    Wu F; Chen Q; Liu C; Duan X; Hu J; Liu J; Cao H; Li W; Li H
    Cancer Med; 2020 Mar; 9(6):2171-2180. PubMed ID: 31975560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of critical alternative splicing events and splicing factors in gastric cancer progression.
    Feng H; Jin Z; Liu K; Peng Y; Jiang S; Wang C; Hu J; Shen X; Qiu W; Cheng X; Zhao R
    J Cell Mol Med; 2020 Nov; 24(21):12667-12680. PubMed ID: 32939931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic Significance.
    Xiong Y; Yang G; Wang K; Riaz M; Xu J; Lv Z; Zhou H; Li Q; Li W; Sun J; Tao T; Li J
    Front Genet; 2020; 11():879. PubMed ID: 32849842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma.
    Shi Y; Chen Z; Gao J; Wu S; Gao H; Feng G
    Oncol Rep; 2018 Oct; 40(4):2014-2022. PubMed ID: 30106437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of an individual alternative splicing prognostic signature in gastric cancer.
    Lou S; Zhang J; Zhai Z; Yin X; Wang Y; Fang T; Xue Y
    Aging (Albany NY); 2021 Feb; 13(4):5824-5844. PubMed ID: 33612482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations Between the Characteristics of Alternative Splicing Events, Prognosis, and the Immune Microenvironment in Breast Cancer.
    Deng Y; Zhao H; Ye L; Hu Z; Fang K; Wang J
    Front Genet; 2021; 12():686298. PubMed ID: 34194482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.